ClinicalTrials.Veeva

Menu

The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status and phase

Completed
Phase 3
Phase 2

Conditions

Type 2 Diabetes

Treatments

Dietary Supplement: Wheat flour
Dietary Supplement: Leucine

Study type

Interventional

Funder types

Other

Identifiers

NCT00643773
MEC-07-1111

Details and patient eligibility

About

The purpose of this study is to determine whether long term leucine supplementation has a positive effect on body composition and muscle characteristics in elderly, type 2 diabetes patients.

Enrollment

60 estimated patients

Sex

Male

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of type 2 diabetes

Exclusion criteria

  • Impaired renal or liver function
  • Cardiac disease
  • Subjects with metal implants
  • Hypertension
  • Diabetes complications
  • Exogenous insulin therapy

Trial design

60 participants in 2 patient groups, including a placebo group

A
Experimental group
Description:
Leucine supplement
Treatment:
Dietary Supplement: Leucine
B
Placebo Comparator group
Description:
Wheat flour
Treatment:
Dietary Supplement: Wheat flour

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems